Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


LSP’s portfolio company Curetis raises EUR 40 million in successful Euronext IPO.


Amsterdam, the Netherlands - 12 November 2015 - Our portfolio company Curetis N.V., a developer of advanced molecular diagnostic assays for severe infectious diseases in hospitalized patients, raised € 40 million in an initial public offering (IPO) through a listing in Euronext Amsterdam and Euronext Brussels. LSP has led the Series A financing of Curetis in 2009 and supported the company in further financings in subsequent years and in the IPO process. For LSP’s Health Economics Fund it is the first of its portfolio companies that becomes listed on the stock market. We are very happy that our portfolio company Curetis is one of a very few European medtech companies that successfully achieved a listing on Euronext this year. A version of the company’s press release can be found here.

About LSP
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors. For more information, please visit lspvc.com

We are looking forward to keeping you informed about further news.

Dr Jörg Neermann, Partner LSP
jneermann@lspvc.com
Tel: +49 (89) 330 6660
lspvc.com

Dr. Rudy Dekeyser, Managing Partner LSP Health Economics Fund
rdekeyser@lspvc.com
Tel: +31 (20) 664 55 00
Lspvc.com


Publisher Contact Information:

Life Sciences Partners (LSP)
+31 (20) 664 55 00
rdekeyser@lspvc.com

Company profile of Life Sciences Partners (LSP)
Past press releases of Life Sciences Partners (LSP).

Data


23,644
Tech investments
From our Online Data Service
15,269
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 10€2.3MSoftware development
Dec 6€5.0MIT services
Dec 5€26.0MEnergy related
Dec 5€5.5MSecurity
Dec 5€16.0MKnowledge management
Dec 4€25.0MBiopharmaceuticals
Dec 4€8.0MInternet services

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises €37.5 million in series a

Apr 5
Fliit
logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...

Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...





About usContact usLegal Information
Copyright © 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.